News
BMXMF
77.00
NaN%
--
Weekly Report: what happened at BMXMF last week (0622-0626)?
Weekly Report · 6d ago
Kepler Capital Keeps Their Buy Rating on bioMerieux (0RUG)
TipRanks · 06/27 12:35
RBC Capital Reaffirms Their Hold Rating on bioMerieux (0RUG)
TipRanks · 06/25 01:47
bioMerieux (0RUG) Receives a Hold from Barclays
TipRanks · 06/25 01:25
bioMerieux downgraded to Underweight from Equal Weight at Morgan Stanley
TipRanks · 06/23 08:27
Weekly Report: what happened at BMXMF last week (0615-0619)?
Weekly Report · 06/22 09:30
bioMerieux price target lowered to EUR 78 from EUR 81 at Deutsche Bank
TipRanks · 06/17 16:21
Weekly Report: what happened at BMXMF last week (0608-0612)?
Weekly Report · 06/15 09:30
Twist Bio favored at Piper despite wait-and-see approach for tools stocks
Seeking Alpha · 06/11 15:24
Weekly Report: what happened at BMXMF last week (0601-0605)?
Weekly Report · 06/08 09:29
Weekly Report: what happened at BMXMF last week (0525-0529)?
Weekly Report · 06/01 09:30
bioMerieux (0RUG) was downgraded to a Hold Rating at UBS
TipRanks · 06/01 08:37
bioMerieux downgraded to Neutral from Buy at UBS
TipRanks · 06/01 08:36
Weekly Report: what happened at BMXMF last week (0518-0522)?
Weekly Report · 05/25 09:32
UBS Keeps Their Buy Rating on bioMerieux (0RUG)
TipRanks · 05/21 16:47
Weekly Report: what happened at BMXMF last week (0511-0515)?
Weekly Report · 05/18 09:32
Weekly Report: what happened at BMXMF last week (0504-0508)?
Weekly Report · 05/11 09:30
Weekly Report: what happened at BMXMF last week (0427-0501)?
Weekly Report · 05/04 09:29
Weekly Report: what happened at BMXMF last week (0420-0424)?
Weekly Report · 04/27 09:30
Barclays Sticks to Its Hold Rating for bioMerieux (0RUG)
TipRanks · 04/25 01:25
More
Webull provides a variety of real-time BMXMF stock news. You can receive the latest news about Biomerieux through multiple platforms. This information may help you make smarter investment decisions.
About BMXMF
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.